WITH 48,661 people testing positive for coronavirus infection in a day, India’s COVID-19 tally climbed to 13,85,522 on Sunday, while the recoveries mounted to 8,85,576, according to the Union Health Ministry data. The country’s death toll rose to 32,063 with 705 fatalities being recorded in a day. There are 4,67,882 active cases of coronavirus infection presently in the country. Thus, around 63.92 per cent people have recovered so far.
The total number of confirmed cases includes foreigners. This is the fourth consecutive day when COVID-19 cases have increased by more than 45,000. The number of tests for detection of COVID-19 has crossed the 16-million mark in the country. According to the ICMR, a cumulative total of 1,62,91,331 samples have been tested up to July 25 with 4,42,263 samples being tested on Saturday.
The Health Ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities. Maharashtra has reported the highest number of cases at 3,66,368, followed by Tamil Nadu 2,06,737, Delhi 1,29,53,Karnataka 90,942, Andhra Pradesh 88,671.
PM to launch testing facilities in Noida, Mumbai and Kolkata today
July 26 (PTI)
PRIME Minister Narendra Modi will launch on Monday “high throughput” COVID-19 testing facilities in Noida, Mumbai and Kolkata, which will ramp up testing capacity and help strengthen early detection and treatment in the country, the Prime Minister’s Office said. The virtual launch event will be attended by Union Health Minister Harsh Vardhan and the Chief Ministers of Maharashtra, West Bengal and Uttar Pradesh -- Uddhav Thackeray, Mamata Banerjee and Yogi Adityanath respectively.
The three high throughput testing facilities have been set up strategically at ICMR institutions -- National Institute of Cancer Prevention and Research in Noida, National Institute for Research in Reproductive Health in Mumbai and National Institute of Cholera and Enteric Diseases in Kolkata. These will be able to test over 10,000 samples in a day, a statement from the Prime Minister’s Office said.
These labs will also reduce turnaround time and exposure of lab personnel to infectious clinical materials. The labs are enabled to test diseases other than COVID-19 as well, and post the pandemic, will be able to test for Hepatitis B and C, HIV, mycobacterium tuberculosis, cytomegalovirus, chlamydia, neisseria and dengue, the statement said.